Tropical island nations, characterized by high temperatures, humidity, and often limited healthcare infrastructure, present a unique spectrum of dermatological challenges. This review synthesizes clinical experiences from the largest dermatological pu...
Tropical island nations, characterized by high temperatures, humidity, and often limited healthcare infrastructure, present a unique spectrum of dermatological challenges. This review synthesizes clinical experiences from the largest dermatological public referral center in Fiji, Tamavua Twomey Hospital, to delineate the prevalence, presentation, and management of skin diseases in the South Pacific. Infectious dermatoses dominate the patient load, with fungal infections and scabies infestations being paramount public health concerns. I highlight the significant burden of Leprosy, which persists at a rate substantially higher than in developed nations, often presenting with severe, multi-bacillary forms and complications like recurrent erythema nodosum leprosum. Management is profoundly constrained by a limited national essential drug list, frequent medication stockouts, and the absence of diagnostic tools such as immunofluorescence examination and fungal culture. Furthermore, skin malignancies in the albino population often face delayed diagnosis and suboptimal treatment, leading to poor outcomes. Dermatological patients in Fiji face limited access to healthcare facilities, inadequate education regarding disease management, and financial barriers to acquiring essential medications, moisturizer and sunscreens. Consequently, their conditions frequently deteriorate and may progress to life-threatening stages. During my three years of practice, I have personally experienced four cases of death among patients with skin diseases. This review serves as a crucial documentation of the dermatological pathology and systemic healthcare hurdles in Fiji, advocating for enhanced international collaboration, improved drug supply chains, and specialized training to fortify the local dermatological capacity